Literature DB >> 1513581

Retained intravitreal lens fragments after cataract surgery.

G D Gilliland1, W L Hutton, D G Fuller.   

Abstract

PURPOSE: The purpose of this study is to review the possible benefits and complications of vitrectomy for retained lens fragments after cataract surgery.
METHODS: The authors reviewed the charts of 65 patients referred over a 12-year period for retained lens fragments after cataract surgery. Of these, 56 underwent vitrectomy and 9 were followed. Of these 56 eyes, 29 (52%) had received an intraocular lens (IOL) at the time of cataract surgery.
RESULTS: Resulting complications from retained lens material included glaucoma (52%), corneal edema (46%), uveitis (56%), and decreased vision (100%). These sequelae responded equally to vitrectomy in eyes with or without an IOL and irrespective of type of cataract surgery (phacoemulsification or extracapsular cataract extraction). The timing of surgery did not statistically influence the final vision or the incidence of glaucoma.
CONCLUSION: Removal of retained lens fragments allows rapid visual restoration, enhances resolution of uveitis, and improves control of glaucoma. Insertion of an IOL at the time of cataract surgery in the face of dislocated lens fragments is not contraindicated provided that it could be performed safely.

Entities:  

Mesh:

Year:  1992        PMID: 1513581     DOI: 10.1016/s0161-6420(92)31814-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  14 in total

1.  Trends in vitreoretinal surgery at a tertiary referral centre: 1987 to 1996.

Authors:  F G Ah-Fat; M C Sharma; M A Majid; J N McGalliard; D Wong
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

2.  Retained intravitreal lens fragments after phacoemulsification: a clinicopathological correlation.

Authors:  L M Yeo; D G Charteris; C Bunce; P J Luthert; Z J Gregor
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

3.  Results of vitrectomy performed at the time of phacoemulsification complicated by intravitreal lens fragments.

Authors:  T Kageyama; M Ayaki; M Ogasawara; C Asahiro; S Yaguchi
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

4.  Medical malpractice claims related to cataract surgery complicated by retained lens fragments (an American Ophthalmological Society thesis).

Authors:  Judy E Kim; Paul Weber; Aniko Szabo
Journal:  Trans Am Ophthalmol Soc       Date:  2012-12

5.  Effects of posterior capsular disruption on the outcome of phacoemulsification surgery.

Authors:  M Mulhern; G Kelly; P Barry
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

6.  Surgical outcomes of 23-gauge vitrectomy for the management of lens fragments dropped into the vitreous cavity during cataract surgery.

Authors:  Kyung Min Koh; Hyoung Seok Kim; Han Joo Cho; Young Ju Lew; Moon Jung Choi; Jung Il Han; Sung Won Cho; Chul Gu Kim; Tae Gon Lee; Jong Woo Kim; Su Jin Yoo
Journal:  Saudi J Ophthalmol       Date:  2014-02-03

7.  Management of nucleus loss into the vitreous: long term follow up in 63 patients.

Authors:  Pedro Romero-Aroca; Juan Fernández-Ballart; Isabel Méndez-Marín; Merce Salvat-Serra; Marc Baget-Bernaldiz; Jose A Buil-Calvo
Journal:  Clin Ophthalmol       Date:  2007-12

Review 8.  Iatrogenic retinal traumas in ophthalmic surgery.

Authors:  Daniele Tognetto; Maria Teresa di Lauro; Daniela Fanni; Adelia Zagidullina; Luca Michelone; Giuseppe Ravalico
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-07-05       Impact factor: 3.117

9.  Intravitreal triamcinolone acetonide injection at the time of pars plana vitrectomy for retained lens material.

Authors:  Na Rae Kim; Jun Ho Yoon; Sung Mo Kang; Hee Seung Chin
Journal:  Korean J Ophthalmol       Date:  2009-03-09

10.  Pars plana vitrectomy and intravitreal phacoemulsification for dropped nuclei.

Authors:  Khalil Ghasemi Falavarjani; Masih Hashemi; Ali Jalili Fazel; Mehdi Modarres; Hossein Nazari; Mohammad-Mehdi Parvaresh
Journal:  J Ophthalmic Vis Res       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.